Adamis Pharmaceuticals Corporation Earning Date (ADMP)

USA |NASDAQ |USD

ADMP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
May 16, 2022 Mar 2022 $-0.03 $-0.06 $-0.24
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
May 16, 2022 Mar 2022 $3.76M $1.45M $3.64M

Adamis Pharmaceuticals Corporation's next earnings date is Monday, May 16, 2022 for the fiscal quarter ending Mar 2022.

ADMP Earnings Date & History Chart

ADMP Earnings & Revenue Forecast

ADMP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $-0.16 $-0.17 $-0.15

ADMP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-0.16 $-0.16 $-0.15

ADMP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 2 $13.17M $10.00M $16.33M

ADMP Earnings Date & Revenue History

ADMP Earnings History

|
Show More
Show More

ADMP Revenue History

|
Show More
Show More

Adamis Pharmaceuticals Corporation Next Earnings Date & Report

ADMP Next Earnings Date & Report Preview: Mar 2022 (FQ)

ADMP's next earnings date is Monday, May 16, 2022 for the fiscal quarter ending Mar 31, 2022.

According to analysts, the average EPS estimation for Adamis Pharmaceuticals Corporation's next quarterly earnings is $-0.03, with a low EPS estimation of $-0.03, and a high estimation of $-0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.03, the last 2 month trend is $-0.03, and the 3 month trend is $-0.05.

Based on analysts, the average revenue estimation is $3.76M, with a low revenue estimation of $3.76M, and a high estimation of $3.76M.

Adamis Pharmaceuticals Corporation Previous Earnings Dates & Reports

ADMP Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Adamis Pharmaceuticals Corporation's previous earnings date was Mar 31, 2022 for its fiscal quarter ended Dec 31, 2021.

ADMP's earnings per share (EPS) was $-0.06, missing the consensus analysts forecast of $-0.04 by -50.00%.

The EPS was higher than the previous fiscal quarter (Sep 2021) by -25.00%, and higher than the same period a year before (Dec 2020) by -75.00%.

Revenues were $1.45M, worse than the forecast of $2.82M by -48.75%, down by -64.82% from the previous quarter , and down by -60.27% from the same period last year.

The company reported a net income of $1.00M.

Free cash flow for the quarter was $-5.68M , compared to $-4.94M last quarter and $-5.39M a year before.

ADMP Previous Earnings Date & Report Recap: Dec 2021 (FY)

Adamis Pharmaceuticals Corporation's previous annual earnings date was Mar 31, 2022 for its fiscal year ended Dec 31, 2021.

ADMP's earnings per share (EPS) was $-0.44, missing the consensus analysts forecast of $-0.27 by 62.96% , and higher than the previous year's EPS (Dec 2020) by -31.25%.

Revenues were $6.22M, worse than the forecast of $11.61M by -46.46%, and down by -62.39% from previous year's revenue.

The company reported a net income of $-11.36M.

Adamis Pharmaceuticals Corporation reported a free cash flow of $-37.79M for its fiscal year, compared to $-21.85M a year ago.